SEQLL INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • December 21st, 2018 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 19th day of February, 2016, by and among SeqLL Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor,” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.
SEQLL INC. FIRST AMENDMENT TO SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • December 21st, 2018 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
This First Amendment to Series A-2 Preferred Stock Purchase Agreement (this “Amendment”) is dated as of January 12, 2018, and is made by and among SeqLL Inc., a Delaware corporation (the “Company”), and certain purchasers of shares of Series A-2 Preferred Stock of the Company (the “Purchasers”) pursuant to that certain Series A-2 Preferred Stock Purchase Agreement, dated February 19, 2016, by and among the Company and the Purchasers (as amended to date, the “Agreement”). Capitalized terms not otherwise defined herein shall have the meaning given them in the Agreement.
AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENTRight of First Refusal and Co-Sale Agreement • December 21st, 2018 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
SEQLL INC. SERIES A-1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries a-1 Convertible Preferred Stock Purchase Agreement • December 21st, 2018 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
THIS SERIES A-1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of the 30th day of May, 2014 by and among SeqLL Inc., a Delaware corporation (the “Company”), the investors listed on Exhibit A attached to this Agreement (each a “Purchaser” and together the “Purchasers”).
LICENSE AGREEMENTLicense Agreement • December 21st, 2018 • SeqLL, Inc. • Laboratory analytical instruments
This License Agreement (this “Agreement”) is made this 15th day of March, 2013, by and between Helicos Biosciences Corporation, a Massachusetts corporation and Chapter 11 debtor-in-possession or its assignee (“Helicos” or the “Licensor”), for the benefit of SEQLL, LLC, a Massachusetts limited liability company (the “Licensee”).
FIRST AMENDMENT TO LEASELease • December 21st, 2018 • SeqLL, Inc. • Laboratory analytical instruments
THIS FIRST AMENDMENT TO LEASE (“this Amendment”) is made this 1st day of April, 2016 and is by and between JAM CAMBRIDGE VENTURES, LLC and RAM CAMBRIDGE VENTURES, LLC, both of which are Massachusetts limited liability companies with a place of business at 237 Lexington Street, Woburn, Massachusetts 01801, (“Landlord”) and SEQLL, LLC a Massachusetts limited liability companies with a place of business at 317 New Boston Street, Woburn, Massachusetts (“Tenant”).
